Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Notes Payables (2016 - 2021)

Bone Biologics has reported Notes Payables over the past 3 years, most recently at $2.9 million for Q3 2017.

  • Quarterly Notes Payables changed N/A to $2.9 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Sep 2017, changed N/A year-over-year, with the annual reading at $1.2 million for FY2016, 325.0% up from the prior year.
  • Notes Payables was $2.9 million for Q3 2017 at Bone Biologics, up from $2.1 million in the prior quarter.
  • Over five years, Notes Payables peaked at $2.9 million in Q3 2017 and troughed at -$533343.0 in Q4 2015.
  • The 3-year median for Notes Payables is $1.6 million (2017), against an average of $1.4 million.
  • The largest YoY upside for Notes Payables was 325.0% in 2016 against a maximum downside of 325.0% in 2016.
  • A 3-year view of Notes Payables shows it stood at -$533343.0 in 2015, then skyrocketed by 325.0% to $1.2 million in 2016, then surged by 140.66% to $2.9 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Notes Payables are $2.9 million (Q3 2017), $2.1 million (Q2 2017), and $1.6 million (Q1 2017).